Clinical trials
Observational Multiple Sclerosis trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 7 |
| Novartis Pharmaceuticals | 3 |
| Bayer | 1 |
| EMD Serono | 1 |
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| Genzyme, a Sanofi Company | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
| Monash University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 16 |
| Recurrence | 2 |
| Demyelinating Diseases | 1 |
| Disease Progression | 1 |
| Fatigue | 1 |
| Multiple Sclerosis, Relapsing-Remitting | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
| Optic Neuritis | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.